Nadia Assenova

Nadia Assenova is an accomplished regulatory affairs executive with extensive experience in the pharmaceutical industry. Currently serving as VP International Regulatory Affairs at Alnylam Pharmaceuticals since October 2025, Nadia leads the International Regulatory Affairs Team and is responsible for global regulatory strategies across multiple markets, including Europe, Asia, and Latin America. Previous roles include VP Regulatory Affairs at Moderna and VP Regulatory Affairs at Arvelle Therapeutics, where Nadia managed regulatory strategies for product approvals and commercialization. A graduate of Medical University in Sofia, Nadia also holds advanced degrees, including a Doctorate in Business Administration and Management from SDA Bocconi, and a Master of Laws in International Business Law from the University of London.